4//SEC Filing
Coherus BioSciences, Inc. 4
Accession 0000899243-16-031223
$CHRSCIK 0001512762operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:05 PM ET
Size
8.4 KB
Accession
0000899243-16-031223
Insider Transaction Report
Form 4
Herman Alan C.
Chief Scientific Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2016-10-03$26.26/sh−3,237$84,998→ 158,450 total - Sale
Common Stock, $0.0001 par value
2016-10-03$25.47/sh−8,096$206,204→ 161,687 total
Holdings
- 300,164(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $25.02 to $26.01, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $26.02 to $26.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001512762
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:05 PM ET
- Size
- 8.4 KB